Company
centrexion.com
Solving unmet needs with a proven track record.
Also known as Centrexion Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Centrexion Therapeutics
Claim, correct or request removal
Record updated 28 September 2026
About
We’re a dynamic company led by experienced leaders in the industry who are strategically building a portfolio with powerful opportunities in two emerging and growing categories: non-opioid pain relief and immunology.
Funding snapshot
- Total raised
- $202MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.3M2023-12-28
Funding rounds
- Round, 2023
- $3.3M2023-12-28, SEC form D sold, 116 investors
- Round, 2023
- $2.3M2023-11-14, SEC form D sold, 2 investors
- Round, 2023
- $10.3M2023-06-14, SEC form D sold, 124 investors
- Round, 2022
- $29.1M2022-05-24, SEC form D sold, 47 investors
- Round, 2021
- $13.5M2021-01-12, SEC form D sold, 17 investors
- Round, 2017
- $69.6M2017-12-18, SEC form D sold, 67 investors
- Round, 2017
- $5.3M2017-04-28, SEC form D sold, 40 investors
- Round, 2016
- $16.6M2016-12-30, SEC form D sold, 14 investors
- Round, 2016
- $11.2M2016-06-14, SEC form D sold, 61 investors
- Round, 2016
- $6.9M2016-04-08, SEC form D sold, 21 investors
- Round, 2016
- $10.5M2016-03-01, SEC form D sold, 25 investors
- Round, 2013
- $8.8M2013-11-20, SEC form D sold, 20 investors
- Round, 2013
- $14.7M2013-11-20, SEC form D sold, 98 investors
Loading relationship preview